A Family-centred Approach Enhancing Cardiovascular Health in Ugandan Adolescents and Their Families
FaCe-D
A Family Centred Approach to Enhance Lifestyle Change and Behavioural Modification for Prevention of Cardiovascular Diseases Among Adolescents and Their Families in Uganda
1 other identifier
interventional
1,280
1 country
2
Brief Summary
The FaCe-D Study, with funding from the Canadian Institute for Health Research (CIHR) through Global Alliance for Chronic Diseases (GACD) aims to adapt and implement an evidence-based family centred approach (FCA) to prevent cardiovascular diseases (CVD) among adolescents and their families. This 5-year implementation science study will be conducted in 16 villages in Jinja district and another 16 in Kampala beginning April 2024 to evaluate the effectiveness of FCA in reducing the risk of CVD in Uganda and to assess feasibility, adoption, while measuring the costs of implementation. The study will be implemented by a group of researchers from MRC/UVRI \& LSHTM, University of British Columbia (Canada), TASO (Uganda) and University of California San Francisco (UCSF) - USA with guidance from the Ministry of Health - Uganda.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2025
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 5, 2025
CompletedFirst Submitted
Initial submission to the registry
August 9, 2025
CompletedFirst Posted
Study publicly available on registry
December 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2028
December 12, 2025
December 1, 2025
1.5 years
August 9, 2025
December 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ideal cardiovascular health
Ideal cardiovascular health (ICH) will be determined by the total score on the American Heart Association's 'Life's Simple 7' tool. The score ranges from 0 to 7 points, where a higher score represents better cardiovascular health.
after 12 months of follow-up
Secondary Outcomes (1)
sleep quality
12 months
Study Arms (2)
FaCe-D Control arm
ACTIVE COMPARATORFaCe-D Intervention
EXPERIMENTALFamily-centred approach for lifestyle changes and behavioural modification
Interventions
Arm Description: They will continue to receive standard care with VHts performing their usual roles of health promotion for both communicable and non-communicable diseases as outlined by the Ministry of Health guidelines. This standard care involves visits by the VHT at least once a quarter to check hygiene and environment, children's immunisation status and other health promotion activities. The VHT may or may not involve the entire family/household.
The participants will receive the FaCe-D intervention comprising of dietary and exercise interventions delivered by Village Health Teams (VHTs)
Eligibility Criteria
You may qualify if:
- Aged 10 -19 years
- Household head/parent has provided consent/permission
- Planning to continue staying in the study village for the next 12 months
You may not qualify if:
- In a boarding school or planning to join a boarding school
- Pregnant or lactating
- Known to have a chronic condition such as mental illness
- The adolescent does not assent or consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- MRC/UVRI and LSHTM Uganda Research Unitlead
- University of Californiacollaborator
- The AIDS Support Organizationcollaborator
- University of British Columbiacollaborator
Study Sites (2)
TASO Jinja
Jinja, Uganda
Kiswa Health center III
Kampala, Uganda
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Prof Rachel King, PhD
University of California, San Francisco
- PRINCIPAL INVESTIGATOR
Prof David Moore, PhD
University of British Columbia
- PRINCIPAL INVESTIGATOR
Dr Josephine Birungi
MRC/UVRI and LSHTM Uganda Research Unit
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 9, 2025
First Posted
December 4, 2025
Study Start
July 5, 2025
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
January 1, 2028
Last Updated
December 12, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- After the publication of the main results with no end date
- Access Criteria
- A link shall be provided
Before data is made available, it will be deidentified